المؤلفون: Garcia-Broncano P., Medrano L.M., Berenguer J., Brochado-Kith O., González-García J., Jiménez-Sousa M.Á., Quereda C., Sanz J., Téllez M.J., Díaz L., JIménez J.L., Resino S., Domingo P., Guardiola J.M., the GESIDA 3603b Study Group

المصدر: JOURNAL OF INFECTION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

مصطلحات موضوعية: interleukin 2 receptor alpha, antivirus agent, gamma interferon inducible protein 10, interleukin 1beta, CD45RA antigen, interleukin 18, ribavirin, tumor necrosis factor, interleukin 6, interleukin 8, interleukin 2, interleukin 4, Article, plasminogen activator inhibitor, male, tumor necrosis factor receptor 1, Human immunodeficiency virus infection, controlled study, human, immunoassay, interleukin 12p70, vascular cell adhesion molecule 1, lymphocyte activation, CD4+ T lymphocyte, fatty acid binding protein 2, nonhuman, controlled clinical trial, adult, ADP ribosyl cyclase/cyclic ADP ribose hydrolase 1, CD8 antigen, biological marker, cohort analysis, prosp, major clinical study, intercellular adhesion molecule 1, mixed infection, female, CD28 antigen, interleukin 7 receptor, D dimer, interleukin 1 receptor blocking agent, lymphocyte subpopulation, gamma interferon, interleukin 10, hepatitis C, CD4 antigen, interleukin 17, peginterferon alpha, memory cell

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::1928d0fb533f78ea988dcf40dbaa9a85
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073554458&doi=10.1016/j.jinf.2019.09.020&partnerID=40&md5=484f103d0905cd14576a7c1e727747cc